Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug is a sulfate-free osmotic laxative combination used primarily for rapid bowel cleansing prior to colonoscopy or barium enema X-ray examinations. It consists of **polyethylene glycol (PEG) 3350**, a non-absorbable polymer, combined with a specific blend of electrolytes: **sodium bicarbonate**, **sodium chloride**, and **potassium chloride**. The mechanism of action relies on the osmotic activity of PEG 3350, which retains water in the intestinal lumen to induce a watery diarrhea that effectively clears the colon. The electrolyte composition is formulated to make the solution isosmotic with body fluids, ensuring that the administration of large volumes (typically 4 liters) results in virtually no net absorption or excretion of ions or water. This sulfate-free formulation was specifically developed by **Braintree Laboratories** (as NuLYTELY) to improve the taste and palatability compared to original PEG-electrolyte solutions (like GoLYTELY), thereby enhancing patient adherence and acceptance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyethylene glycol 3350 + sodium bicarbonate + sodium chloride + potassium chloride.